However, regression analysis showed that progressive decreases of ANG 1–7, ANG 1–9, and MasR in T2DM recipients were independent of the immunosuppressive state, including covariables such as polyclonal anti-lymphocyte antibodies, cyclosporine, tacrolimus, mycophenolate mofetil, everolimus, and prednisone. Here, MAS1L is linked to type 2 diabetes mellitus.